Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,218 public trials 94 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

NCT01164709

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Congenital Abnormalities, +42 more
Locations: Inselspital Bern Bern, Switzerland

Kantonsspital Graubuenden Chur, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00397579

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Congenital Abnormalities, +16 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia

NCT00860522

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: Penn State Hershey Cancer Institute Hershey, Pennsylvania, United States

View Trial Details

Completed

Respiratory Training in Patients With Leukemia

NCT03876834

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: Faculty of Physical Therapy Cairo, Egypt

View Trial Details

Completed

RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

NCT00968253

Conditions: Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

NCT00936117

Conditions: Bacterial Infections and Mycoses, Bone Marrow Diseases, Bone Marrow Neoplasms, +10 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Interleukin-2 in Treating Patients With Myelodysplastic Syndrome

NCT00002746

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

NCT00458848

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ospedale Civile Alessandria Alessandria, Italy

Ospedale Torrette University Ancona Ancona, Italy

Ospedale S. Donato Arezzo, Italy

Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy

View all 66 locations

View Trial Details

Completed

Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

NCT00943319

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab

NCT01416974

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details